Date | Name | Shares | Transaction | Value |
Apr 7, 2025
| Lori A. Flees President & CEO; Director |
9,522
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 4, 2025
| Dione R. Sturgeon Chief Accounting Officer |
278
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Feb 27, 2025
| Julie M. O'Daniel Chief Legal Officer |
15,305
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $37.4 per share |
572,407.00
|
Feb 26, 2025
| Carol H. Kruse Director |
N/A
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $36.59 per share |
0.00
|
Nov 26, 2024
| Mary E. Meixelsperger Chief Financial Officer |
5,280
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Mary E. Meixelsperger Chief Financial Officer |
13,330
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Julie M. O'Daniel Chief Legal Officer |
6,480
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Lori A. Flees President & CEO; Director |
45,680
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Jonathan L. Caldwell Chief People Officer |
1,970
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Jonathan L. Caldwell Chief People Officer |
4,950
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Robert Dobbins Chief Technology Officer |
1,360
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Robert Dobbins Chief Technology Officer |
3,430
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Linne Fulcher Chief Operating Officer |
3,020
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Nov 26, 2024
| Linne Fulcher Chief Operating Officer |
7,620
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|